Gregory T. Hebrank

Statistics

Publications

Citations

215

H-Index

Active since

2017

Affiliations

Knopp Biosciences (United States)(Current)

Gregory T. Hebrank is an author at Knopp Biosciences (United States) specializing in pharmacotherapy, eosinophilic disease therapy, and immunopharmacology.

Publications per year

2017–2018

Publications

Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size

Tanya M. Laidlaw, Calman Prussin, Reynold A. Panettieri et al. · The Laryngoscope · 2018 · 114 citations

Medicine, Otolaryngology, Pharmacotherapy +16

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Sandhya R. Panch, Michael Bozik, Thomas Brown et al. · Blood · 2018 · 63 citations · Full text

Pharmacy, Pharmacotherapy, Inflammation +6

The targeted eosinophil-lowering effects of dexpramipexole in clinical studies

Steven I. Dworetzky, Gregory T. Hebrank, Donald Archibald et al. · Blood Cells Molecules and Diseases · 2017 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +11

1–3 of 3